JPI 547, also known as NOV 1402, is an oral inhibitor of PARP 1/2 and Tankyrase 1/2. JPI-547 demonstrated anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and immune checkpoint inhibitors.
Molecular Weight:
473.402
CAS Number:
[2055357-65-6]
Formula:
C23H26Cl2N6O
Target:
Others
T69955
* VAT and and shipping costs not included. Errors and price changes excepted